DefiniGEN will be attending ASGCT

Come and meet DefiniGEN at booth #1745 and hear how our iPSC-derived hepatocyte platform (Opti-HEP) can:

• Be applied to any modality;
• Is engineered to recapitulate disease phenotypes; and
• Offers diverse genetic backgrounds for screening.